P2X(7) receptor in the kidneys of diabetic rats submitted to aerobic training or to N-acetylcysteine supplementation [corrected].

Previous studies in our laboratory showed that N-acetylcysteine supplementation or aerobic training reduced oxidative stress and the progression of diabetic nephropathy in rats. The P2X(7 receptor is up-regulated in pathological conditions, such as diabetes mellitus. This up-regulation is related to oxidative stress and induces tissue apoptosis or necrosis. The aim of the present study is to assess the role of P2X(7) receptor in the kidneys of diabetic rats submitted to aerobic training or N-acetylcysteine supplementation. Diabetes was induced in male Wistar rats by streptozotocin (60 mg/kg, i.v.) and the training was done on a treadmill; N-acetylcysteine was given in the drinking water (600 mg/L). By confocal microscopy, as compared to control, the kidneys of diabetic rats showed increased P2 × 7 receptor expression and a higher activation in response to 2'(3')-O-(4-benzoylbenzoyl) adenosine5'-triphosphate (specific agonist) and adenosine triphosphate (nonspecific agonist) (all p<0.05). All these alterations were reduced in diabetic rats treated with N-acetylcysteine, exercise or both. We also observed measured proteinuria and albuminuria (early marker of diabetic nephropathy) in DM groups. Lipoperoxidation was strongly correlated with P2X(7) receptor expression, which was also correlated to NO•, thus associating this receptor to oxidative stress and kidney lesion. We suggest that P2X(7) receptor inhibition associated with the maintenance of redox homeostasis could be useful as coadjuvant treatment to delay the progression of diabetic nephropathy.

Introduction

Diabetes mellitus (DM) is an emerging global health problem; thirty percent of diabetic patients develop nephropathy, which is one of the major factors contributing to morbidity and mortality in these patients [1].

Recent studies in our laboratory showed the beneficial role of N-acetylcysteine (NAC) supplementation [2] in the oxidative stress and the progression of diabetic nephropathy. NAC is an antioxidant that acts as a free radical scavenger; it also provides cysteine, which is one of the most important sources for glutathione synthesis. Glutathione (GSH) acts intra and extracellularly as an antioxidant eliminating the reactive oxygen species (ROS), being produced naturally by the body [3].

Ji and colleagues [4] showed that blood GSH increases during prolonged exercise and would help to reduce oxidative stress; however, other studies show that training of moderate or low-intensity could reduce stress levels, directly through the glycemic control [5], [6].

Many other factors appear to contribute to the pathophysiology of diabetes, as for example, Thaning and colleagues [7] demonstrated that the vasodilatatory effect of the purinergic (P2) receptors is attenuated in these patients. These P2 receptors are formed mainly by receptors sensitive to extracellular ATP, and comprise two subfamilies, P2Y and P2X. The P2X subgroup consists of seven members (P2X1–7), which act as ligand-gated ion channels, mediating rapid changes in membrane permeability to cations [8]. Others studies have shown that P2X7 receptor (P2X7-R) is expressed in normal rat kidneys and in two chronic models of glomerular injury: streptozotocin-induced diabetics and in hypertensive animals [9].

The aim of the present study is to assess the P2X7-R in the kidneys of diabetic rats submitted to aerobic training or N-acetylcysteine supplementation.

Methods

Male Wistar rats with 7 weeks of age and weighing between 170 to 210 g were obtained from the Central Animal Housing of Escola Paulista de Medicina. The protocol was approved by the Ethics Committee in Research of Universidade Federal de Sao Paulo, protocol # 0486/09. The animals were placed, in average, five/cage and they received temporary mark on the tail. All of them passed through a preselection for running; we did it because there are animals that do not adapt to a treadmill exercise routine, and these ones were allocated to the sedentary group and the others to the exercise group. From this point, they were randomly assigned to the formation of subgroups: CTL+SE (sedentary control); CTL+SE+NAC (sedentary control plus NAC); CTL+EX (trained control); CTL+EX+NAC (trained control plus NAC); DM+SE (sedentary diabetic); DM+SE+NAC (sedentary diabetic plus NAC); DM+EX (trained diabetic); DM+EX+NAC (trained diabetic plus NAC); n = 10 for each group.

Surgical Procedure

The unillateral nephrectomy was done in all the animals in order to accelerate the development of diabetic nephropathy. The animals were anaesthetized with ketamine chloridrate (67 mg/kg,i.m.; Dopalen, Sesp, Sao Paulo, Brazil) and xylazine chloridrate (9 mg/kg,i.m.; Xilazina, Rhobiofarma, Sao Paulo, Brazil) [10], and the left kidney was removed. All the procedures were performed under sterile conditions and the animals rested for one week following the surgery [11]. After surgery, they received analgesic buprenorphine (0.05 mg/kg, sc) (Bupaq, Richterpharma, Brazil) given each 6 hours and supplemented with carprofen (5 mg/kg, sc) (Rimadyl, Oetis, Brazil) given each 12 hours [12].

Metabolic Cages

All animals were placed in metabolic cages (Tecniplast, Italy), receiving water/NAC and chow ad libitum for 24 hours; the NAC/water and food ingestion were recorded. The metabolic cages evaluation was done before and after the experimental protocol of 8 weeks, and at the end of this period, we collected samples of 24 hours’ urine and a small aliquot of blood from the retro-orbital plexus, after 3 hours of fasting (same day); these samples were stored at −20°C.

DM Induction

Half of the animals received a single administration of streptozotocin (STZ, 60 mg/kg BW,i.v.; Sigma-Aldrich, Sao Paulo, Brazil) dissolved in 0.1 M citrate buffer, pH4.5, and the other half received the vehicle. DM was confirmed 48 hours after induction with STZ and defined as fasting blood glucose >200 mg/dL [13].

Physical Training

The exercise protocol started on the fifth day after induction of DM; it consisted of a moderate running on a motordriven treadmill during 60 min/day at 16 m/min, 5 days/week, during 8 weeks at no inclination (0%). The training program was preceded by an one week period of adaptation to the aerobic exercise, this adaptation was made in periods of 10, 20 and 30 minutes with speed of 10 m/min, with 2 min of interval for each time. After the adaptation week, every day the running speed was increased gradually, until the rats ran at the standard speed of 16 m/min [14].

Euthanasia

At the end of the protocol the animals were sacrificed with a high dose of anesthetic (ketamine chloridrate at 90 mg/kg and xylazine chloridrate at 18 mg/kg, both i.m.) followed by perforation of the diaphragm.

Nac Supplementation

The antioxidant NAC (Zambon Ltda, Sao Paulo, Brazil) was given in the drinking water, at a concentration of 600 mg/L, daily, for 8 weeks. The animals were allowed to drink it ad libitum [15], beginning on the fifth day of DM, and NAC daily consumption was estimated through amount of solution ingered by the animals.

Renal Function

Plasma and urinary levels of creatinine were measured by colorimetric assay using a Labtest Creatinine kit (Centerlab Ltda, Sao Paulo, Brazil). The plasma urea concentrations were measured using a Labtest Urea CE kit (Centerlab Ltda, Sao Paulo, Brazil). The proteinuria was measured by colorimetric assay using a Sensiprot Labtest kit (Centerlab Ltda, Sao Paulo, Brazil). The albuminuria, an early marker of diabetic nephropathy, was determined by the method of radial immunodiffusion [16].

Estimation of Lipid Peroxidation

Lipid peroxidation was estimated by the thiobarbituric acid reactive substances (TBARS) method [17], with a molar extinction coefficient of 1.56×105 cm/mol [18], [19] in plasma [20], urine [15] and kidney [21] at the end of the 8 week protocol.

Measurement of Glutathione Enzyme Activity

Glutathione peroxidase (GPx) and glutathione reductase (GSR) activities were measured in renal tissue. For GPx activity, an enzyme-linked immunosorbent assay (ELISA) kit (E90295Ra Uscn Life Science Inc, Sao Paulo, Brazil) was used, and for GSR activity, an ELISA kit (E91314Ra Uscn Life Science Inc, Sao Paulo, Brazil) was used. The enzymatic activity was expressed as the GSR to GPx ratio [22].

NO• Measurement

The levels of NO of the plasma, renal cortex and urinary samples were measured by chemiluminescence using a Nitric Oxide Analyzer (NOA280, Sievers Instruments Inc, CO, USA) [23], a high-sensitivity detector for measuring NO, which is based on the following gas-phase chemiluminescent reaction between NO and ozone:

The emission of a photon from electrically excited nitrogen dioxide is in the red and near-infrared region of the spectrum, and is detected by a thermoelectrically cooled red-sensitive photomultiplier tube. The sensitivity for measurement of NO• and its reaction products in liquid samples is ∼1picomole.

Immunoblotting of Inos and Enos in the Kidneys

To determine the expression of eNOS and iNOS proteins, 40?g of total protein of each sample was separated on 8% polyacrylamide gels. The blots were then incubated with an anti-iNOS antibody (1∶200, Santa Cruz Biotechnology, CA, USA) or an anti-eNOS antibody (1∶500, BD Transduction Laboratories, CA, USA). The labeling was visualized using a secondary antibody conjugated with peroxidase for iNOS (1:5,000, Millipore Corporation, MA, USA) or eNOS (1∶500, Sigma-Aldrich, MO, USA). The bands were visualized by chemiluminescence (Amersham Pharmacia Biotech, NJ, USA) and analyzed by gel documentation (Alience4.7 Uvitec, Cambridge, United Kingdom). As a loading control, the blots were incubated with an anti-actin antibody (1∶500, Santa Cruz Biotechnology, CA, USA) which was visualized using a secondary antibody conjugated with peroxidase (1∶10,000; Sigma-Aldrich, MO, USA).

Immunohistochemistry Analysis of P2X7-R

We used a method adapted to renal tissues using the primary antibody anti-P2×7-R (1∶200; Chemicon, CA, USA). Control slides were processed without primary antibody. The percentage of P2X7-R in the glomeruli was expressed as a ratio of the staining area in the glomeruli to the total area [24].

Ca2+ Measurement by Confocal Microscopy

After sacrifice, the kidneys were immediately sectioned to 40µm and labeled with 10µM Fluo-4 (Invitrogen, Sao Paulo, Brazil) and pluronic 0.02% (Sigma-Aldrich, Sao Paulo, Brazil) for 1 hour. Analysis was performed by confocal laser scanning microscopy and the device was adjusted to capture the fluorescence of the focal section. The images were obtained with an argon laser (λex = 488 nm) and fluorescence was detected from 500 nm to 550 nm (LSM 780 Carl Zeiss, Jena, Germany). The activity of P2×7-R was assessed by the mobilization of Ca2+ by 100 µM BzATP (B6396, Sigma-Aldrich, Sao Paulo, Brazil) (a specific agonist to P2X7-R) and by 1 mM ATP (A6779, Sigma-Aldrich, Sao Paulo, Brazil) (a nonspecific agonist). The fluorescence intensity of the Fluo-4 was normalized to the basal intensity (Ft/F0), as shown in the illustrative picture, and the quantification of the brightness was expressed in arbitrary units of fluorescence (auf) [25].

Histological Analysis

At the end of the 8-week protocol, the kidneys were removed under anesthesia. Half of each kidney was fixed in 10% formaldehyde and embedded in paraffin, sectioned to a 4 µm thickness and stained with hematoxylin–eosin (HE), and periodic acid-Schiff reagent (PAS). The analysis was carried out at a magnification of x400 and analyzed by a pathologist under blinded conditions.

Statistical Analysis

The results are expressed as mean ±SEM and the values were compared using two-way analysis of variance (ANOVA) with Newman-Keuls post-test or non-paired T-Student test as indicated. Nonlinear regression test of polynomial type of 2nd or 3rd order was performed, and we calculated the r2 to analyze the curve linearity and significance was adjusted to the model. Significance was defined as p<0.05. The data were analyzed utilizing the software IBM SPSS Statistics 19.

Results

Metabolic Profile

At the 8th week of aerobic training and/or NAC supplementation, we observed no alterations among the non-diabetic groups, opposite to the diabetic animals. The non-diabetic group, received in average, 26.6 mg/kg BW of NAC, while the diabetic groups received 264.6 mg/kg BW. When compared to CTL+SE, DM+SE rats had higher glycemia, diuresis, chow and water intake, and a reduction in body weight. NAC or aerobic training improved the metabolic profile and gain in body weight in diabetic rats; these effects were more pronounced in the animals that received both treatments (Table 1).

Table 1

Metabolic profile and analysis of renal function at the 8th week protocol.

Parameters	CTL+SE	CTL+SE+NAC	CTL+EX	CTL+EX+NAC	DM+SE	DM+SE+NAC	DM+EX	DM+EX+NAC
Chow Intake	16.9±0.5	18.1±1.7	18.3±0.6	16.9±0.8	35.4±1.3a	27.4±1.8b	25.7±1.2b	26.6±0.9b
(mg/24 hr)
Liquid Intake	20.0±1.36	20.3±1.3	17.3±0.7	15.7±0.9	155.1±7.8a	117.7±9.6b	117.0±5.3b	109.2±5.5b
(mL/24 hr)
Diuresis	13.4±0.4	16.2±1.6	13.7±0.5	13.8±0.7	143.4±8.3a	95.3±2.5b	87.5±5.2b	91.3±2.6b
(mL/24 hr)
Body Weight	424.4±6.3	421.4±10.6	406.4±11.0	388.4±4.2	186.4±6.6a	241.2±10.4b	271.9±10.5b,c	277.0±7.4b,c
(g)
Plasma Creatinine	0.85±0.05	0.91±0.07	0.92±0.06	0.91±0.1	1.81±0.07a	1.13±0.1b	0.85±0.04b,c	0.91±0.03b,c
(mg/dL)
Creatinine Clearance	1.07±0.08	1.01±0.07	1.3±0.07	1.4±0.17	0.5±0.06a	1.1±0.1b	1.4±0.17b	1.4±0.23b
(mL/min)
Plasma Urea	44.7±2.4	44.2±2.7	34.3±1.8	41.4±4.3	106.3±20.5a	77. 6±7.6b	77.1±9.0b	67.8±4.4b
(mg/dL)
Blood Glucose	105.0±2.8	107.9±2.7	99.1±2.4	105.8±1.8	526.1±15.7a	399.6±10.6b	322.7±6.8b,c	294.3±9.0b,c,d
(mg/dL)
Albuminuria	2.06±0.44	3.24±0.7	4.59±0.7	3.3±0.36	26.98±1.75a	12.53±0.65b	12.30±1.78b	10.84±0.43b
(mg/24 hr)
Proteinuria	9.8±0.9	8.8±0.5	12.7±0.85	13.0±0.9	38.0±2.7a	23.9±1.6b	13.5±0.5b,c	12.6±1.0b,c
(mg/24 hr)

Results are represented as mean ±SEM. Albuminuria with n = 5 and all others parameters with n = 10. two-way ANOVA with Newman-Keuls post-test; p<0.05: a vs. CTL+SE; b vs. DM+SE; c vs. DM+SE+NAC; d vs. DM+EX.

CTL+SE, sedentary control; CTL+SE+NAC, sedentary control plus NAC; CTL+EX, training control; CTL+EX+NAC, training control plus NAC; DM+SE, sedentary diabetic; DM+SE+NAC, sedentary diabetic plus NAC; DM+EX, training diabetic; DM+EX+NAC, training diabetic plus NAC.

At the end of the 8th week, the renal function of normoglycemic rats submitted to NAC or training was unchanged. The diabetic animals showed significant increases in plasma urea and creatinine, with a reduction in creatinine clearance and increase in proteinuria and albuminuria. NAC administration and/or training improved these parameters of renal function (Table 1).

At the end of the 8th week, the DM+SE rats had the higher levels of TBARS compared to the CTL+SE rats in the plasma (nmol/mL) and urine (nmol/24 hr) (8.9±0.4 vs. 5.8±0.23; 596.6±28.2 vs. 78.1±3.5; p<0.05; respectively) (Table 2). Plasma and urine TBARS were reduced following NAC (5.1±0.4; 288.7±10.7; respectively) or after exercise (4.2±0.2; 242.9±12.1; respectively) and when administered together, the treatments resulted in additional improvements in plasma (2.9±0.25) and urine (237.1±4.8) (Table 2). DM+SE had a high estimated value of lipidic peroxidation in the renal cortex compared to CTL+SE rats (1.2±0.2 vs. 0.6±0.1). This value was significantly reduced in the group treated with NAC (0.6±0.1), in trained animals (0.6±0.2) or in animals that received both treatments (0.7±0.1) (Table 2). We analyzed TBARS excretion in relation to the development of proteinuria, a marker for diabetic nephropathy. According to the nonlinear regression, proteinuria and TBARS excretion were significantly related (p<0.001 and r2 = 0.713) (Figure 1a).

Table 2

xidative stress analysis at the 8th week protocol.

Parameters	CTL+SE	CTL+SE+NAC	CTL+EX	CTL+EX+NAC	DM+SE	DM+SE+NAC	DM+EX	DM+EX+NAC
Plasma TBARS	5.8±0.23	4.8±0.4	4.9±0.2	4.7±0.1	8.9±0.4 a	5.1±0.4 b	4.2±0.2 b	2.9±0.25 b,c,d
(nmol/mL)
TBARS Excretion	78.1±3.5	75.5±5.8	80.6±1.9	78.8±4.1	596.6±28.2 a	288.7±10.7 b	242.9±12.1 b,c	237.1±4.8 b,c
(nmol/24 hr)
Renal TBARS	0.6±0.1	0.6±0.1	0.6±0.05	0.8±0.1	1.2±0.2 a	0.6±0.1 b	0.6±0.2 b	0.7±0.1 b
(nmol/mg protein)
GSR/GPx	3.8±0.7	5.2±0.3	11.8±1.9 a	11.1±0.9 a	1.8±0.2	4.6±0.5	6.2±1.5 b	10.9±2.1 b,c,d
Plasma NO	46.3±3.1	50.2±2.9	61.8±5.5	63.1±6.8	60.5±2.6	60.5±2.4	66.7±6.8	71.3±3.3
(µmol/L)
NO• Excretion	35.4±4.8	39.6±5.4	58.7±4.1 a	57.9±4.3 a	2.4±0.4 a	3.8±0.6	23.9±2.0 b,c	29.9±2.6 b,c
(µmol/24 hr)
Renal Tissue NO	931.3±42.6	1230±133.7	1459±77.4	1468±291.6	1082±42.6	1747±173.5 b	2510±425.6 b	2490±228.0 b
(µmol/mg protein)

Results are represented as mean ±SEM. All parameters with n = 10. two-way ANOVA with Newman-Keuls post-test; p<0.05: a vs. CTL+SE; b vs. DM+SE; c vs. DM+SE+NAC; d vs. DM+EX.

CTL+SE, sedentary control; CTL+SE+NAC, sedentary control plus NAC; CTL+EX, training control; CTL+EX+NAC, training control plus NAC; DM+SE, sedentary diabetic; DM+SE+NAC, sedentary diabetic plus NAC; DM+EX, training diabetic; DM+EX+NAC, training diabetic plus NAC; TBARS, thiobarbituric acid reactive substances; GSR, glutathione reductase enzyme; GPx, glutathione peroxidase enzyme; NO•, nitric oxide.

Figure 1

Oxidative stress and diabetic nephropathy at the 8th week of protocol.

Nonlinear regression oxidative stress, NO• and proteinuria, n = 10 for all groups. a) TBARS urinary excretion and proteinuria are related (p<0.001 and r2 = 0.713); b) NO• urinary excretion and proteinuria are also linked (p<0.001 and r2 = 0.706); c) TBARS and NO• urinary excretion are dependent (p<0.001 and r2 = 0.660) (n = 10). CTL+SE, sedentary control; CTL+SE+NAC, sedentary control plus NAC; CTL+EX, training control; CTL+EX+NAC, training control plus NAC; DM+SE, sedentary diabetic; DM+SE+NAC, sedentary diabetic plus NAC; DM+EX, training diabetic; DM+EX+NAC, training diabetic plus NAC; TBARS, thiobarbituric acid reactive substances; NO•, nitric oxide.

We analyzed the enzymatic activity by assessing the ratio of glutathione reductase (GSR) and glutathione peroxidase (GPx) in renal tissue, at the end of the 8th week (Table 2). We observed that in CTL+EX and CTL+EX+NAC rats, the GSR to GPx ratio was significantly increased compared to CTL+SE rats (11.8±1.9; 11.1±0.9 vs. 3.8±0.7). These values were reduced in the DM+SE (1.8±0.2) compared to CTL+SE animals, although not significantly. DM+SE+NAC (4.6±0.5; NS), DM+EX (6.2±1.5; p<0.05) and DM+EX+NAC (10.9±2.1; p<0.05) had an increase in this ratio, when compared to DM+SE rats (Table 2).

Measurement of NO•

After the 8th week of the protocol the plasma concentrations of NO• had no difference among all groups; however, we observed that NO• excretion was significantly increased in CTL+EX and CTL+EX+NAC compared to CTL+SE animals (58.7±4.1; 57.9±4.3 vs. 35.4±4.8; respectively). Compared to CTL+SE, NO• excretion was reduced in DM+SE (2.4±0.4) (p<0.05); In DM+SE+NAC it was unchanged (3.8±0.6), and significantly increased in DM+EX (23.9±2.0) and DM+EX+NAC animals (29.9±2.6) when compared to DM+SE (Table 2). Using regression, we found that the variables NO• excretion and proteinuria were related (p<0.001). Specifically, the increase in excreted NO• was linked with a reduction in proteinuria r2 = 0.706 (Figure 1b). We also used regression test to assess the relation between TBARS and NO• excretion and we observed a dependence (p<0.001 and r2 = 0.660) between these variables (Figure 1c).

Normoglycemic groups showed no changes in renal NO• and these levels were similar in the DM+SE and CTL+SE group (1,082±42.6 vs. 931.3±42.6). There were significant increases in renal NO• levels in DM+SE+NAC (1,747±173.5), DM+EX (2,510±425.6) and DM+EX+NAC (2,490±228.0) compared to DM+SE animals (Table 2).

Western Blot of NOS in the Renal Cortex

We observed that there was no difference in iNOS among the control animals. However, in diabetic animals, the DM+SE had higher values when compared to CTL+SE animals (0.31±0.18 vs. 0.075±0.007; p<0.0002). The other diabetic groups showed a reduction in these values after NAC supplementation (0.097±0.015; p<0.002), aerobic training (0.082±0.024; p<0.0075) or both (0.110±0.019; p<0.0039), when compared to DM+SE animals (Figure 2).

Figure 2

Western blot analysis of iNOS in samples of renal cortex at the 8th week of protocol.

Non-paired T- Student test; significance for p<0.05. iNOS, inducible nitric oxide synthase.

The analysis of the protein levels of eNOS showed that among the control animals, there was no difference between the groups. In contrast, in diabetic animals, we observed that levels of eNOS in the DM+EX+NAC was increased compared to DM+SE animals, but it was not statistically significant (0.75±0.13 vs. 0.56±0.088) (Figure 3).

Figure 3

Western blot analysis of eNOS in samples of renal cortex at the 8th week of protocol.

eNOS, endothelial nitric oxide synthase.

Immunohistochemical Analysis of P2×7-R

In all non-diabetic groups, there were no differences in renal tissue in P2×7-R, as determined by immunohistochemistry. In the diabetic animals P2×7-R had the highest expression in the DM+SE compared to CTL+SE rats (43.25±5.45%; p<0.05). The diabetic rats treated with NAC showed attenuated P2×7-R expression (34.87±4.34%; p<0.05), which was reduced to a greater extent in the trained group (25.60±3.44%; p<0.05), and the combination of both resulted in an additional reduction (3.85±0.56%; p<0.05) when compared to DM+SE (Figure 4).

Figure 4

Immunohistochemistry analysis of P2×7-R in the kidney at the 8th week of protocol.

Two-way ANOVA with Newman-Keuls post-test. p<0.05: a vs. CTL+SE; b vs. DM+SE; c vs. DM+SE+NAC; d vs. DM+EX. CTL+SE, sedentary control; CTL+SE+NAC, sedentary control plus NAC; CTL+EX, training control; CTL+EX+NAC, training control plus NAC; DM+SE, sedentary diabetic; DM+SE+NAC, sedentary diabetic plus NAC; DM+EX, training diabetic; DM+EX+NAC, training diabetic plus NAC; P2X7-R, P2X7 receptor.

Intracellular Calcium Measurement and P2×7-R in Kidneys by Confocal Microscopy

Longitudinal sections of the kidneys were incubated with a Fluo-4 fluorescence probe that increases the intensity of fluorescence when binding to calcium (Ca2+). When 1 mM ATP, a nonspecific agonist for P2X and P2Y, was used, we observed that non-diabetic groups did not show differences in Ca2+ influx. The DM+SE animals had the strongest response to ATP (0.38±0.16 vs. 0.034±0.01; p<0.05) and this influx was reduced in DM+SE+NAC, DM+EX and DM+EX+NAC, when compared to DM+SE, although not significantly (Figure 5a, 5b and 5c).

Figure 5

Confocal analysis of P2×7-R in the kidney at the 8th week of protocol.

a) Intracellular calcium concentration by confocal microscopy. Intensity was quantified using pseudocolor image according to fluorescence intensity by Fluo-4; these images showed the calcium mobilization in renal tissue when exposed to ATP 1 mM. Micrographies were obtained with x400 of magnification. b) ­Graphics of the calcium dynamics in relation to basal fluorescence. c) Quantification after the nonspecific agonist. Each group with n = 5, Two-way ANOVA with Newman-Keuls post-test. p<0.05: a vs. CTL+SE; b vs. DM+SE. CTL+SE, sedentary control; CTL+SE+NAC, sedentary control plus NAC; CTL+EX, training control; CTL+EX+NAC, training control plus NAC; DM+SE, sedentary diabetic; DM+SE+NAC, sedentary diabetic plus NAC; DM+EX, training diabetic; DM+EX+NAC, training diabetic plus NAC; auf, arbitrary unit fluorescence.

When we administered 100 µM of BzATP, a preferential agonist of P2×7-R, we observed again that there was no difference among the non-diabetic groups in the Ca2+ influx. In diabetic animals, the DM+SE group showed increased fluorescence compared to CTL+SE animals (1.0±0.23 vs. 0.14±0.06; p<0.05). In the DM+SE+NAC (0.27±0.06), DM+EX (0.31±0.08) and DM+EX+NAC (0.17±0.04) groups, this fluorescence intensity was significantly reduced compared to the DM+SE group (Figure 6a, 6b and 6c).

Figure 6

Confocal analysis of P2×7-R in the kidney at the 8th week of protocol.

a) Intracellular calcium concentration by confocal microscopy. Intensity was quantified using pseudocolor image according to fluorescence intensity by Fluo-4; these images showed the calcium mobilization in renal tissue when exposed to BzATP 100µM. Micrographies were obtained with x400 of magnification. b) ­Graphics of the calcium mobilization in relation to basal fluorescence. c) Quantification after the specific agonist. Each group with n = 5, Two-way ANOVA with Newman-Keuls post-test. p<0.05: a vs. CTL+SE; b vs. DM+SE. CTL+SE, sedentary control; CTL+SE+NAC, sedentary control plus NAC; CTL+EX, training control; CTL+EX+NAC, training control plus NAC; DM+SE, sedentary diabetic; DM+SE+NAC, sedentary diabetic plus NAC; DM+EX, training diabetic; DM+EX+NAC, training diabetic plus NAC; auf, arbitrary unit of fluorescence.

P2X7-R and Diabetic Nephropathy

We observed a correlation between P2×7-R activity, as determined by BzATP, and proteinuria (p<0.001 and r2 = 0.526) (Figure 7). P2X7-R was also related with TBARS (p<0.001 and r2 = 0.783) and NO• (p<0.001 and r2 = 0.449).

Figure 7

P2X7-R activity and diabetic nephropathy at the 8th week of protocol.

Nonlinear regression between the oxidative stress, P2X7-R and proteinuria. calcium dynamic by BzATP and proteinuria are also related (p<0.001 and r2 = 0.526) (n = 5). CTL+SE, sedentary control; CTL+SE+NAC, sedentary control plus NAC; CTL+EX, training control; CTL+EX+NAC, training control plus NAC; DM+SE, sedentary diabetic; DM+SE+NAC, sedentary diabetic plus NAC; DM+EX, training diabetic; DM+EX+NAC, training diabetic plus NAC; TBARS, thiobarbituric acid reactive substances; NO•, nitric oxide; BzATP, 2′(3′)-O-(4-benzoylbenzoyl) adenosine 5′ –triphosphate; P2X7-R, P2X7 receptor.

By HE staining the diabetic groups showed serious histological modifications. Specifically, the DM+SE animals had alterations in mesangial cells, i.e., increasing mesangium matrix, and frequent tubular vacuolization and degeneration, mainly in the distal tubule (10∶12). In contrast, DM+SE+NAC animals only showed tubular vacuolization (7∶12), and this phenomenon was strongly reduced in DM+EX and DM+EX+NAC animals (4∶12 for both) (Figure 8). The PAS stain showed no alterations among the control groups. On the other hand, we observed that in DM+SE animals, there was an intense glycosidic degeneration, which was attenuated by NAC administration or aerobic training; this reduction was most evident when the treatments were combined (Figure 9).

Figure 8

HE staining of renal tissue at the 8th week of protocol.

The black arrows on the micrographies show that tubular vacuolization, in DM+SE were present at proportion of 10∶12. In DM+SE+NAC this proportion was 6∶12, DM+EX and DM+EX+NAC had 04:12. Magnification of x400. CTL+SE, sedentary control; CTL+SE+NAC, sedentary control plus NAC; CTL+EX, training control; CTL+EX+NAC, training control plus NAC; DM+SE, sedentary diabetic; DM+SE+NAC, sedentary diabetic plus NAC; DM+EX, training diabetic; DM+EX+NAC, training diabetic plus NAC; HE, hematoxylin and eosin.

Figure 9

PAS staining of renal tissue at the 8th week of protocol.

The black arrows on the micrographies show glycosidic degeneration in the tubules. DM+SE presented these alterations in medulla and renal cortex. There was a reduction in DM+SE+NAC and DM+EX with incidence only in the renal cortex; the DM+EX+NAC was the less affected. Magnification with x400. CTL+SE, sedentary control; CTL+SE+NAC, sedentary control plus NAC; CTL+EX, training control; CTL+EX+NAC, training control plus NAC; DM+SE, sedentary diabetic; DM+SE+NAC, sedentary diabetic plus NAC; DM+EX, training diabetic; DM+EX+NAC, training diabetic plus NAC; PAS, periodic acid-Schiff.

Discussion

Previous studies with diabetic animals, in our laboratory, showed that NAC promoted renoprotective effects, with substantial improvements in renal function and control of oxidative stress, increasing NO• bioavailability [2]. These results were similar to those obtained with aerobic training, which reestablished the redox balance, delayed endothelial dysfunction and improved NO• levels, with preservation of the glomerular structures and reduction of albuminuria and renal injury [14]. Therefore, the strategies above could be useful as adjuvant treatments against diabetic nephropathy. In the present study, we observed that the combination of NAC and aerobic training produced significant improvements in metabolic parameters and controlled oxidative stress (NO•, iNOS, TBARS and glutathione). Notably, we observed that, in the renal tissues of diabetic animals, NAC supplementation and/or aerobic training resulted in the reduced expression and activity of P2×7-R.

The main effect of NAC supplementation and aerobic exercise was on hyperglycemia, which is characteristic of DM, and stimulates the production of oxidative stress [26]. NAC is a potent antioxidant that decreases the ROS mainly by stimulating glutathione synthesis [27]. The exercises increase the glutathione levels [28], and in addition, decrease the hyperglycemia [29], consequently reducing the oxidative stress. Afolayan and Sunmonu [30] showed in theirs studies that glutathione peroxidase and glutathione reductase are significantly reduced in diabetic animals. These antioxidant enzymes were shown to be increased by a moderate training [31], and such changes were more intense when the participants received antioxidant supplementation in addition to exercise [32]. All of these studies corroborate with our findings and suggest that the treatments reduced lipoperoxidation and increased the GSH production.

The action of the glutathione enzymes is relevant for the maintenance of redox homeostasis, which is important for the preservation of many organs, including the kidney.

The oxidative stress from diabetes causes damage in to renal tissue which is evidente with markers such as microalbuminuria. Although there is a study showing the albuminuria resulting from exercises [33], the majority of the investigations show the opposite, i.e. exercises had a renoprotective function with decrease of albuminuria. These studies corroborate with our findings, in other words, the diabetic animals have the highest albuminuria and proteinuria and with NAC supplementation and/or aerobic training there were significant reduction in both values. We observed that proteinuria in diabetic rats was strongly linked to lipid peroxidation and NO•. i.e. the diabetic animals that had the highest proteinuria had the highest lipoperoxidation and the lowest NO• levels.

The diabetic animals that received NAC supplementation or exercises showed a reduction in oxidative stress and an increase in NO• bioavailability. Notably, when both treatments were given in combination, the best control of redox homeostasis was achieved.

Our findings are also in agreement with some papers that have demonstrated the beneficial effects of aerobic training in reducing oxidative stress [34] or increasing the antioxidant defense [35]. However, in these studies, the authors observed that this protective action of exercises was eliminated when the training was performed at a great workload.

We also analyzed the expression of NOS isoforms. Initially, we analyzed the inducible enzyme, which is synthesized in response to external stimuli or by pathologies as the diabetes [36]; however, this iNOS production look like to be modulate by oxidative stress, thus the action of antioxidants could reduce its expression [10]. Likewise the administration of antioxidantes, the use of protocols with aerobic training also showed decrease of iNOS [37]. All these studies corroborate with our findings that iNOS protein expression was increased in diabetic animals and it was significantly reduced by NAC supplementation and/or aerobic training.

The eNOS isoform is a constitutive enzyme that, in our protocol, did not show altered expression in the control groups after NAC supplementation or aerobic exercise. However, among the diabetic groups, we observed a slight increase in eNOS in the animals that received NAC and exercises. This effect could be due to the improved preservation of the endothelial cells against the damages from DM. Grutzmacher and colleagues [38] showed that the endothelial injury from DM begins in the early phase of the disease. With diabetes progression, the oxidative stress becomes the major factor for DM development as it is responsible for the uncoupling of eNOS, leading to a failure of NO• production and becomes a source of superoxide anion (O2 • –) [39], [40]. This uncoupling, however, can be reverted by the administration of an antioxidant [41].

At the kidney hystology, the most significant changes were seen in the tubules, including the vacuolization and glycosidic degeneration observed in the renal cortex and medulla. In animals that were supplemented with NAC or the ones who received aerobic training, these alterations were reduced; this protection was increased when both treatments were given together. These findings are similar to unpublished observations about DM, from our laboratory, and they corroborate with reports from other researchers showing that antioxidant treatment [42] or the regular aerobic exercises contributed to reduce the injuries and preserved the renal structure in animals with DM [43].

Given the link between oxidative stress and diabetes, and the strong modulation of P2X7 receptor by the oxidative stress, we decided to evaluate its expression [44]. Our findings showed that P2X7-R expression was strongly correlated with lipoperoxidation, which is corroborated by others that have demonstrated that this receptor can induce ROS and RNS production [45]. However, there are no studies that show the opposite, in other words, whether redox homeostasis compromise the P2×7-R activation is unclear. Recent papers showed that proinflammatory cytokines and hyperglycemia can both act on p38 MAPK mechanisms and increase extracellular ATP levels, resulting in the increased expression of P2X7-R [46], [47]. In our study, we observed that exercises and/or NAC administration reduced the P2X7-R expression in the kidneys of diabetic animals, suggesting us the interdependence of this receptor to oxidative stress.

The activation of P2X7-R increases the permeability of the cell membrane, allowing the transport of many cations, including calcium (Ca2+). An increase in cytoplasmic Ca2+ may cause cell swelling and cell death by necrosis or apoptosis [48], [49]. A recent study by Bourzac and colleagues[50] reported additional functions of this receptor, and showed that the membrane activity of glucose transporter-2 could be down-regulated by P2X7-R activation; thus this receptor can modulate the absorption of glucose and can promote uncontrolled hyperglycemia. When we evaluated Ca2+ mobility, diabetic animals had the highest levels of Ca2+ influx, reflecting highly activated P2X7-R and blood glucose, which were significantly reduced with NAC administration and/or aerobic training.

Our findings are supported by studies that have shown that the influx of Ca2+ can be modulated in the intracellular environment, by free radicals and voltage-dependent Ca2+ channels. In this case, ROS acts as an agonist, binding to the intracellular terminals of the receptor and opening the pores [51]. On the other hand, a category of free radicals, including reactive nitrogen species (RNS), have been shown to act as antagonists that inhibit Ca2+ influx. This effect is believed to be a result of nitrosylation by NO• in the intracellular terminals of the receptor [51], [52].

A study by Coddou and colleagues [53] showed that the P2×2a and P2×4 receptors could be modulated by redox balance, and specifically, that extracellular ATP functions as an agonist and that these receptors could be activated by intracellular ROS. These findings emphasize that P2ΣX7-R is not only a sensor of extracellular ATP but may also respond to intracellular stimuli that changes depending on the redox homeostasis of the cell.

Our study suggests that the use of strategies that modulate P2X7 receptor, such as NAC or aerobic training, especially when both are associated, they result in renoprotective action, reducing diabetic nephropathy.

To our knowledge, this study is the first to show the possible modulation of P2X7-R by NO•, because we have seen that when oxidative stress is reduced, NO• bioavailability is increased; is this situation NO• could perhaps be inhibiting the receptor through its nitrosylation. We believe that these findings need more investigations to identify the intracellular pathways that would modulate P2×7-R activity, and hence this, could provide therapeutic targets to the prevention of diabetic complications.